\-\ Texto\\:\\ \ \(0\)\
\-\ oral\\ course\\ of\\ metronidazole\\ or\\ vancomycin\\.\ \(0\)\
\-\ diffuse\\ bowel\\ wall\\ thickening\\ of\\ entire\\ colon\\,\\ demonstrating\\ \\"accordion\\ sign\\,\\"\\ \\(oral\\ contrast\\ trapped\\ between\\ markedly\\ thickened\\ haustral\\ folds\\)\\.\\ \\ pericolonic\\ ascites\\ and\\ mild\\ pericolonic\\ stranding\\.\ \(0\)\
\-\ pseudomembranous\\ colitis\ \(3\)\
\-\ inflammatory\\ colitis\ \(0\)\
\-\ radiation\\ enteritis\ \(0\)\
\-\ hypoproteinemia\ \(1\)\
\-\ leukemia\\/lymphoma\ \(1\)\
\-\ ischemic\\ colitis\ \(5\)\
\-\ bowel\\ wall\\ hemorrhage\\ \\(henoch\\-schonlein\\ disease\\)\ \(0\)\
\-\ fever\\,\\ abdomenal\\ pain\\,\\ leukocytosis\\,\\ foul\\-\\ smelling\\ diarrhea\\ after\\ course\\ of\\ antibiotics\\ for\\ treatment\\ of\\ pneumonia\\.\ \(0\)\
\-\ in\\ approximately\\ half\\ the\\ cases\\ of\\ pmc\\,\\ pancolitis\\ will\\ be\\ present\\ \\(not\\ expected\\ in\\ ischemia\\,\\ hemorrhage\\,\\ inflammatory\\ bowel\\ disease\\)\\.\\ \\ hypoproteinemia\\ would\\ show\\ other\\ hollow\\ viscus\\ thickening\\.\\ radiation\\ enteritis\\ would\\ correspond\\ to\\ the\\ radiated\\ port\\.\\ pmc\\ is\\ confirmed\\ by\\ stool\\ assay\\ for\\ c\\.\\ dificile\\ toxin\\.\\ \\ \ \(0\)\
\-\ ct\\ findings\\ do\\ not\\ necessarily\\ correlate\\ with\\ clinical\\ severity\\ and\\ negative\\ ct\\ findings\\ do\\ not\\ exclude\\ pmc\\,\\ thus\\ a\\ high\\ degree\\ of\\ clinical\\ suspicion\\ must\\ be\\ maintained\\ since\\ delayed\\ diagnosis\\ may\\ be\\ fatal\\.\ \(0\)\
\-\ the\\ patient\\ in\\ the\\ above\\ example\\ had\\ a\\ ct\\ 2\\ weeks\\ before\\ the\\ prior\\ study\\,\\ showing\\ pneumonia\\,\\ but\\ normal\\ appearance\\ of\\ bowel\\.\\ \\ after\\ development\\ of\\ pmc\\ \\(presumably\\ from\\ antibiotic\\ tx\\)\\,\\ she\\ was\\ treated\\ with\\ antibiotics\\ \\(flagyl\\)\\,\\ with\\ significant\\ improvement\\ in\\ clinical\\ parameters\\,\\ allowing\\ discharge\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pmc\\:\\ 0\\.16175263163241282\ \(0\)\
\-\ hypoproteinemia\\:\\ 0\\.07451716737070233\ \(0\)\
\-\ colitis\\:\\ 0\\.06451904640717532\ \(0\)\
\-\ pericolonic\\:\\ 0\\.0573446703349079\ \(0\)\
\-\ enteritis\\:\\ 0\\.056031818558387965\ \(0\)\
\-\ bowel\\:\\ 0\\.04917345931898641\ \(0\)\
\-\ foul\\-\\:\\ 0\\.040438157908103206\ \(0\)\
\-\ dificile\\:\\ 0\\.040438157908103206\ \(0\)\
\-\ clinical\\:\\ 0\\.03618316238622942\ \(0\)\
\-\ accordion\\:\\ 0\\.0353986519967816\ \(0\)\
\-\ henoch\\-schonlein\\:\\ 0\\.0353986519967816\ \(0\)\
\-\ abdomenal\\:\\ 0\\.03407900946259912\ \(0\)\
\-\ pancolitis\\:\\ 0\\.03407900946259912\ \(0\)\
\-\ do\\:\\ 0\\.03403277935840292\ \(0\)\
\-\ leukemia\\/lymphoma\\:\\ 0\\.03305541519051559\ \(0\)\
\-\ assay\\:\\ 0\\.03305541519051559\ \(0\)\
\-\ oral\\:\\ 0\\.033032868498692775\ \(0\)\
\-\ pneumonia\\:\\ 0\\.03240655683695881\ \(0\)\
\-\ haustral\\:\\ 0\\.03151196456381278\ \(0\)\
\-\ hollow\\:\\ 0\\.03151196456381278\ \(0\)\
\-\ flagyl\\:\\ 0\\.030899435239847076\ \(0\)\
\-\ smelling\\:\\ 0\\.030359146085459993\ \(0\)\
\-\ toxin\\:\\ 0\\.030359146085459993\ \(0\)\
\-\ viscus\\:\\ 0\\.029875840967763544\ \(0\)\
\-\ course\\:\\ 0\\.029582857279409555\ \(0\)\
\-\ antibiotics\\:\\ 0\\.029446939061197257\ \(0\)\
\-\ metronidazole\\:\\ 0\\.029039503551277514\ \(0\)\
\-\ parameters\\:\\ 0\\.029039503551277514\ \(0\)\
\-\ pseudomembranous\\:\\ 0\\.02867233516745395\ \(0\)\
\-\ trapped\\:\\ 0\\.028332390341060734\ \(0\)\
\-\ correspond\\:\\ 0\\.028015909279193982\ \(0\)\
\-\ necessarily\\:\\ 0\\.028015909279193982\ \(0\)\
\-\ would\\:\\ 0\\.02789877870112009\ \(0\)\
\-\ inflammatory\\:\\ 0\\.027186384809101138\ \(0\)\
\-\ vancomycin\\:\\ 0\\.0269315570862388\ \(0\)\
\-\ thickening\\:\\ 0\\.026574537336636256\ \(0\)\
\-\ radiated\\:\\ 0\\.02647245865249117\ \(0\)\
\-\ port\\:\\ 0\\.02647245865249117\ \(0\)\
\-\ fatal\\:\\ 0\\.02647245865249117\ \(0\)\
\-\ presumably\\:\\ 0\\.026259064085358635\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.026094097102532438\ \(0\)\
\-\ radiation\\:\\ 0\\.025727075684058135\ \(0\)\
\-\ allowing\\:\\ 0\\.025319640174138392\ \(0\)\
\-\ maintained\\:\\ 0\\.02454028679434299\ \(0\)\
\-\ correlate\\:\\ 0\\.024399132396789074\ \(0\)\
\-\ tx\\:\\ 0\\.024262192198854757\ \(0\)\
\-\ leukocytosis\\:\\ 0\\.02412922184622516\ \(0\)\
\-\ folds\\:\\ 0\\.023751982863486756\ \(0\)\
\-\ wall\\:\\ 0\\.022707881837052718\ \(0\)\
\-\ c\\.\\:\\ 0\\.02268035510577343\ \(0\)\
\-\ ascites\\:\\ 0\\.022493098250175928\ \(0\)\
\-\ stool\\:\\ 0\\.02158093834767517\ \(0\)\
\-\ example\\:\\ 0\\.02158093834767517\ \(0\)\
\-\ severity\\:\\ 0\\.021289592449866335\ \(0\)\
\-\ exclude\\:\\ 0\\.02082042341720387\ \(0\)\
\-\ half\\:\\ 0\\.020694740049368478\ \(0\)\
\-\ diarrhea\\:\\ 0\\.020337118299507417\ \(0\)\
\-\ suspicion\\:\\ 0\\.020337118299507417\ \(0\)\
\-\ antibiotic\\:\\ 0\\.020059023704019182\ \(0\)\
\-\ thus\\:\\ 0\\.019500780883021387\ \(0\)\
\-\ entire\\:\\ 0\\.01926788030791394\ \(0\)\
\-\ ischemic\\:\\ 0\\.019089715934903558\ \(0\)\
\-\ expected\\:\\ 0\\.019089715934903558\ \(0\)\
\-\ discharge\\:\\ 0\\.01900316325460822\ \(0\)\
\-\ stranding\\:\\ 0\\.018960491728634305\ \(0\)\
\-\ markedly\\:\\ 0\\.018554283483948778\ \(0\)\
\-\ degree\\:\\ 0\\.018363917745844408\ \(0\)\
\-\ improvement\\:\\ 0\\.018289929755340356\ \(0\)\
\-\ ischemia\\:\\ 0\\.018217116227100493\ \(0\)\
\-\ be\\:\\ 0\\.0181342668350082\ \(0\)\
\-\ showing\\:\\ 0\\.018039983951284987\ \(0\)\
\-\ must\\:\\ 0\\.017869438064854925\ \(0\)\
\-\ thickened\\:\\ 0\\.017577577074578726\ \(0\)\
\-\ \\,\\:\\ 0\\.01738505007909185\ \(0\)\
\-\ development\\:\\ 0\\.01707233129889787\ \(0\)\
\-\ demonstrating\\:\\ 0\\.01701638967920146\ \(0\)\
\-\ not\\:\\ 0\\.01699291750103581\ \(0\)\
\-\ findings\\:\\ 0\\.016686577392568437\ \(0\)\
\-\ before\\:\\ 0\\.016591841250920517\ \(0\)\
\-\ \\(\\:\\ 0\\.016567929501005975\ \(0\)\
\-\ ct\\:\\ 0\\.016449132844844627\ \(0\)\
\-\ \\)\\:\\ 0\\.016365543397094156\ \(0\)\
\-\ after\\:\\ 0\\.016220194519350483\ \(0\)\
\-\ delayed\\:\\ 0\\.01595403827644578\ \(0\)\
\-\ colon\\:\\ 0\\.015394187659735502\ \(0\)\
\-\ confirmed\\:\\ 0\\.0147403651517743\ \(0\)\
\-\ since\\:\\ 0\\.014398002851826682\ \(0\)\
\-\ above\\:\\ 0\\.0143666910854487\ \(0\)\
\-\ sign\\:\\ 0\\.01358002982460583\ \(0\)\
\-\ fever\\:\\ 0\\.01326267259886223\ \(0\)\
\-\ cases\\:\\ 0\\.013058765431106113\ \(0\)\
\-\ study\\:\\ 0\\.01289739154522917\ \(0\)\
\-\ disease\\:\\ 0\\.012814105882712883\ \(0\)\
\-\ between\\:\\ 0\\.012424291450569926\ \(0\)\
\-\ will\\:\\ 0\\.012263674396234598\ \(0\)\
\-\ approximately\\:\\ 0\\.012127604708970565\ \(0\)\
\-\ show\\:\\ 0\\.012032825387576267\ \(0\)\
\-\ diffuse\\:\\ 0\\.011867006515483097\ \(0\)\
\-\ treated\\:\\ 0\\.011733260715981006\ \(0\)\
\-\ negative\\:\\ 0\\.011706973217315939\ \(0\)\
\-\ appearance\\:\\ 0\\.011210580627223127\ \(0\)\
\-\ weeks\\:\\ 0\\.011125127325234626\ \(0\)\
\-\ she\\:\\ 0\\.011003606153459506\ \(0\)\
\-\ high\\:\\ 0\\.010727275509526677\ \(0\)\
\-\ significant\\:\\ 0\\.010540583261716622\ \(0\)\
\-\ mild\\:\\ 0\\.01032226355014283\ \(0\)\
\-\ prior\\:\\ 0\\.010064737487166806\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.00963364696161384\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.00944839221092772\ \(0\)\
\-\ other\\:\\ 0\\.009035039214231416\ \(0\)\
\-\ diagnosis\\:\\ 0\\.00900100610449734\ \(0\)\
\-\ present\\:\\ 0\\.008853251164824225\ \(0\)\
\-\ contrast\\:\\ 0\\.008774200398201402\ \(0\)\
\-\ may\\:\\ 0\\.00859783655457855\ \(0\)\
\-\ had\\:\\ 0\\.008458026693764718\ \(0\)\
\-\ 2\\:\\ 0\\.008440846314268561\ \(0\)\
\-\ but\\:\\ 0\\.008360106885474944\ \(0\)\
\-\ treatment\\:\\ 0\\.007934022750462785\ \(0\)\
\-\ in\\:\\ 0\\.007732059268628531\ \(0\)\
\-\ for\\:\\ 0\\.0066890655838781204\ \(0\)\
\-\ by\\:\\ 0\\.006526930748829701\ \(0\)\
\-\ normal\\:\\ 0\\.006145011259628904\ \(0\)\
\-\ from\\:\\ 0\\.00580933813373492\ \(0\)\
\-\ pain\\:\\ 0\\.004787193429040068\ \(0\)\
\-\ or\\:\\ 0\\.004594141050292237\ \(0\)\
\-\ was\\:\\ 0\\.004533383129420582\ \(0\)\
\-\ of\\:\\ 0\\.004275368836623429\ \(0\)\
\-\ patient\\:\\ 0\\.003929320784020128\ \(0\)\
\-\ a\\:\\ 0\\.003638530291913773\ \(0\)\
\-\ the\\:\\ 0\\.0031708551537528856\ \(0\)\
\-\ is\\:\\ 0\\.0025793154971776406\ \(0\)\
\-\ to\\:\\ 0\\.001959028020380671\ \(0\)\
\-\ \\.\\:\\ 0\\.0017912609957376562\ \(0\)\
\-\ and\\:\\ 0\\.0016514587681854904\ \(0\)\
\-\ with\\:\\ 0\\.0016101492122461891\ \(0\)\
